Sionna Therapeutics (SION) Return on Capital Employed (2025 - 2026)
Sionna Therapeutics' (SION) quarterly Return on Capital Employed came in at 32.36% in Q1 2026, down 362.0% year-on-year from 12.35% in Q1 2025, and down 16.69% quarter-over-quarter from 27.73% in Q4 2025.
Sionna Therapeutics (SION) Return on Capital Employed (2025 - 2026) Analysis & Trends
Sionna Therapeutics has disclosed Return on Capital Employed across 2 years of filings, most recently posting 32.36% for Q1 2026.
- Return on Capital Employed for Q1 2026 came in at 32.36%, down 362.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 32.36% (down 362.0% YoY), and the FY2025 annual result was 36.45%, changed N/A from the prior year.
- Return on Capital Employed came in at 32.36% for Q1 2026 at Sionna Therapeutics, down from 27.73% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 24.82% in Q2 2025 to a low of 32.36% in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | 450.31% |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | 51.73% |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | -107.40% |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 21.10% |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | -50.43% |
| 10 | Sionna Therapeutics | 1.61 Bn | 1.61 Bn | - | -32.36% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -32.36% |
| Dec 31, 2025 | -27.73% |
| Sep 30, 2025 | -24.87% |
| Jun 30, 2025 | -24.82% |
| Mar 31, 2025 | -28.74% |